Position in KURA
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$584,595
-$157,739 QoQ
Shares Held
71,906
+0.6% QoQ
Ownership
0.081%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
17 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in KURA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ALPS ADVISORS INC holds $156,743,120 across 93 Biotechnology names. KURA ranks #63 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
496,682 | $23,825,835 | |
| 2 | KYMR |
Kymera Therapeutics, Inc.
|
66,457 | $5,535,203 | |
| 3 | CGON |
CG Oncology, Inc.
|
68,737 | $4,652,120 | |
| 4 | MIRM |
Mirum Pharmaceuticals, Inc.
|
49,128 | $4,538,444 | |
| 5 | CELC |
Celcuity Inc.
|
37,663 | $4,298,854 | |
| 6 | APLS |
Apellis Pharmaceuticals, Inc.
|
104,058 | $4,186,253 | |
| 7 | XENE |
Xenon Pharmaceuticals Inc.
|
67,723 | $3,938,092 | |
| 8 | APGE |
Apogee Therapeutics, Inc.
|
45,586 | $3,836,973 |
All Filings in KURA
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $584,595 | 71,906 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $742,334 | 71,447 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $344,990 | 38,982 | Shares | Defined | 2025-11-05 | |
| 2025-06-30 | $269,228 | 46,660 | Shares | Defined | 2025-08-11 | |
| 2024-09-30 | $1,146,900 | 58,695 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,223,107 | 59,403 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,145,421 | 53,700 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $725,888 | 50,479 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $499,310 | 54,749 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $532,258 | 50,308 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $551,487 | 45,093 | Shares | Defined | 2023-05-10 | |
| 2022-12-31 | $574,247 | 46,273 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $498,139 | 36,467 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $724,493 | 39,525 | Shares | Defined | 2022-08-15 | |
| 2020-09-30 | $2,199,186 | 71,775 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $1,212,508 | 74,387 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $819,780 | 82,390 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||